| Product Code: ETC6657710 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Canada Gout Therapeutics Market Overview | 
| 3.1 Canada Country Macro Economic Indicators | 
| 3.2 Canada Gout Therapeutics Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Canada Gout Therapeutics Market - Industry Life Cycle | 
| 3.4 Canada Gout Therapeutics Market - Porter's Five Forces | 
| 3.5 Canada Gout Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F | 
| 3.6 Canada Gout Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Canada Gout Therapeutics Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Growing prevalence of gout in Canada due to lifestyle factors like obesity and unhealthy diets | 
| 4.2.2 Increasing awareness about gout and its management leading to higher diagnosis rates | 
| 4.2.3 Advancements in gout therapeutics, including new drug developments and treatment options | 
| 4.3 Market Restraints | 
| 4.3.1 High cost associated with gout therapeutics limiting access to treatment for some patients | 
| 4.3.2 Concerns regarding potential side effects and safety issues of gout medications | 
| 4.3.3 Limited reimbursement options for gout therapeutics under certain healthcare plans in Canada | 
| 5 Canada Gout Therapeutics Market Trends | 
| 6 Canada Gout Therapeutics Market, By Types | 
| 6.1 Canada Gout Therapeutics Market, By Drug Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Canada Gout Therapeutics Market Revenues & Volume, By Drug Type, 2021- 2031F | 
| 6.1.3 Canada Gout Therapeutics Market Revenues & Volume, By NSAIDS, 2021- 2031F | 
| 6.1.4 Canada Gout Therapeutics Market Revenues & Volume, By Colchicine, 2021- 2031F | 
| 6.1.5 Canada Gout Therapeutics Market Revenues & Volume, By Corticosteroids, 2021- 2031F | 
| 6.1.6 Canada Gout Therapeutics Market Revenues & Volume, By Urate-lowering Drugs, 2021- 2031F | 
| 6.1.7 Canada Gout Therapeutics Market Revenues & Volume, By Biologics, 2021- 2031F | 
| 6.2 Canada Gout Therapeutics Market, By Distribution Channel | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Canada Gout Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F | 
| 6.2.3 Canada Gout Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F | 
| 6.2.4 Canada Gout Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F | 
| 7 Canada Gout Therapeutics Market Import-Export Trade Statistics | 
| 7.1 Canada Gout Therapeutics Market Export to Major Countries | 
| 7.2 Canada Gout Therapeutics Market Imports from Major Countries | 
| 8 Canada Gout Therapeutics Market Key Performance Indicators | 
| 8.1 Average time to diagnosis of gout in Canada | 
| 8.2 Patient adherence rates to prescribed gout medications | 
| 8.3 Percentage of gout patients achieving target serum uric acid levels | 
| 8.4 Number of clinical trials and research studies focused on gout therapeutics | 
| 8.5 Adoption rates of emerging gout treatments and therapies | 
| 9 Canada Gout Therapeutics Market - Opportunity Assessment | 
| 9.1 Canada Gout Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F | 
| 9.2 Canada Gout Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Canada Gout Therapeutics Market - Competitive Landscape | 
| 10.1 Canada Gout Therapeutics Market Revenue Share, By Companies, 2024 | 
| 10.2 Canada Gout Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |